Neurology News and Research

Latest Neurology News and Research

CWRU, UH Neurological Institute to present 2013 Neurocritical Care & Stroke Conference

University Hospitals (UH) Neurological Institute, in partnership with Case Western Reserve University School of Medicine, will present the 10th Annual Cleveland Neurocritical Care & Stroke Conference: With a Little Help From My Friends on March 8, 2013 at Case Western Reserve University's Iris S. and Bert L. Wolstein Research Building.

18 Dec 2012

Telestroke networks can improve bottom line of patients and hospitals

Telestroke networks that enable the remote and rapid diagnosis and treatment of stroke can improve the bottom line of patients and hospitals, researchers report.

18 Dec 2012

Physicians should not prescribe cognitive enhancers to healthy people

Physicians should not prescribe cognitive enhancers to healthy individuals, states a report being published today in the Canadian Medical Association Journal (CMAJ).

18 Dec 2012

‘Ambu-lysis’ edges closer for stroke patients

A pilot trial of giving suitable stroke patients intravenous thrombolysis before their arrival in hospital has produced promising results.

17 Dec 2012

Naurex announces completion of $38M Series B financing

Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced the completion of a $38 million Series B financing led by new investor Baxter Ventures.

17 Dec 2012

Blocking single tiny blood vessel in the brain can harm neural tissue and even alter behavior

Blocking a single tiny blood vessel in the brain can harm neural tissue and even alter behavior, a new study from the University of California, San Diego has shown. But these consequences can be mitigated by a drug already in use, suggesting treatment that could slow the progress of dementia associated with cumulative damage to miniscule blood vessels that feed brain cells.

17 Dec 2012

Bayer files radium-223 NDA with FDA for treatment of CRPC patients with bone metastases

Bayer HealthCare today announced that the company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for radium Ra 223 dichloride (radium-223), an investigational compound for the treatment of castration-resistant prostate cancer (CRPC) patients with bone metastases.

15 Dec 2012

Cedars-Sinai physician-scientist receives grant to study Charcot-Marie-Tooth disease

A Cedars-Sinai physician-scientist has been awarded a $3 million grant from the California Institute for Regenerative Medicine to study with new stem cell technology Charcot-Marie-Tooth disease, the most common inherited neurological disorder and which damages nerves that control muscles.

14 Dec 2012

Survey identifies career burnout as significant problem among hospital-based neurologists

A survey has identified career burnout as a significant problem among neurologists who predominantly work with hospital inpatients.

14 Dec 2012

Cedars-Sinai scientist to study Charcot-Marie-Tooth disease

14 Dec 2012

Fingolimod associated with modest, rapid increase in macular volume

Patients with multiple sclerosis treated with fingolimod undergo a modest but rapid increase in macular volume, research shows.

13 Dec 2012

Heartbeat Experts announces increased revenue and expanded clients in emerging markets

Heartbeat Experts, the global leader in stakeholder management solutions for the life sciences industry, announced today increased revenue and expanded clients across Brazil, Russia, China, India and Korea. Heartbeat Experts' reported combined revenue from these markets grew 50% in the third quarter of 2012.

13 Dec 2012

Dantrolene may help combat Duchenne muscular dystrophy in boys

Drugs are currently being tested that show promise in treating patients with Duchenne muscular dystrophy (DMD), an inherited disease that affects about one in 3,600 boys and results in muscle degeneration and, eventually, death.

13 Dec 2012

Takeda, Lundbeck announce FDA acceptance of vortioxetine NDA submission

Takeda Global Research & Development Center, Inc., (Takeda) and H. Lundbeck A/S (Lundbeck) jointly announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing their submission of a New Drug Application (NDA) for vortioxetine for the treatment of major depressive disorder (MDD) in adult patients.

13 Dec 2012

Researchers discover a trigger by which the HCV enters liver cells

Researchers at the University of Southern California (USC) have discovered a trigger by which the Hepatitis C virus enters liver cells ─ shedding light on how this serious and potentially deadly virus can begin to damage the liver.

13 Dec 2012

AC253 drug appears to restore memory in Alzheimer's brain cells

Medical researchers at the University of Alberta have discovered a drug intended for diabetes appears to restore memory in Alzheimer's brain cells.

11 Dec 2012

Dementia therapy: an interview with Assoc Prof. Olivier Piguet and Sharon Savage

Dementia is the umbrella term used to describe a number of neurodegenerative brain disorders that cause progressive changes in thinking abilities and behaviour. The kind of deficits experienced by individuals diagnosed with dementia depends on the location and severity of the pathology in the brain.

11 Dec 2012

Neurology News and Research

Latest Neurology News and Research

CWRU, UH Neurological Institute to present 2013 Neurocritical Care & Stroke Conference

Telestroke networks can improve bottom line of patients and hospitals

Physicians should not prescribe cognitive enhancers to healthy people

‘Ambu-lysis’ edges closer for stroke patients

Naurex announces completion of $38M Series B financing

Blocking single tiny blood vessel in the brain can harm neural tissue and even alter behavior

Bayer files radium-223 NDA with FDA for treatment of CRPC patients with bone metastases

Cedars-Sinai physician-scientist receives grant to study Charcot-Marie-Tooth disease

Survey identifies career burnout as significant problem among hospital-based neurologists

Cedars-Sinai scientist to study Charcot-Marie-Tooth disease

Fingolimod associated with modest, rapid increase in macular volume

Heartbeat Experts announces increased revenue and expanded clients in emerging markets

Dantrolene may help combat Duchenne muscular dystrophy in boys

Takeda, Lundbeck announce FDA acceptance of vortioxetine NDA submission

Researchers discover a trigger by which the HCV enters liver cells

AC253 drug appears to restore memory in Alzheimer's brain cells

Dementia therapy: an interview with Assoc Prof. Olivier Piguet and Sharon Savage

Recurrence unlikely in childhood cryptogenic stroke

Cedars-Sinai first in Los Angeles County to achieve Comprehensive Stroke Center Certification

Carbon nanotubes can help regulate chloride levels in nerve cells that contribute to neural injuries

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Neurology News and Research

Latest Neurology News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in